TrialBreast cancer research and treatment2021

Lack of cross-resistance between non-steroidal and steroidal aromatase inhibitors in breast cancer patients: the potential role of the adipokine leptin.

Nazli Bahrami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.